Literature DB >> 27476499

Economic costs to caregivers of diarrhoea treatment among children below 5 in rural Gujarat India: findings from an external evaluation of the DAZT programme.

Samuel D Shillcutt1, Amnesty E LeFevre2, Christa L Fischer Walker1, Sunita Taneja3, Robert E Black1, Sarmila Mazumder3.   

Abstract

INTRODUCTION: Diarrhoea is a leading cause of mortality among young children in India although few receive the recommended treatment. The diarrhoea alleviation through zinc and oral rehydration salts (ORS) therapy (DAZT) team initiated a programme in Gujarat from 2011 to 2013 to increase coverage of these interventions through public and private providers at scale. This study evaluates the economic impact of diarrhoea to caregivers before and after the introduction of zinc and ORS at scale through the DAZT programme.
METHODS: The DAZT programme evaluation took a before-and-after study design using a two-stage clustered cross-sectional survey. Factors associated with the odds of caregivers incurring economic costs and their amounts were evaluated in a two-part modelling approach.
RESULTS: The DAZT programme lowered unadjusted economic costs to caregivers of treating a diarrhoeal episode from $4.04 to $2.49 in 2 years. Controlling for covariates, analysis showed no association between the programme and a change in odds of incurring an economic cost but did show an association with a reduction in economic cost of $2.15 (95% confidence interval (CI) $1.20-$3.11) per diarrhoea episode. A more than 4-fold increase in care-seeking from public community health workers, reduction in care-seeking from higher levels of the health system and reduced spending on drugs besides ORS and zinc may explain these results. DISCUSSION: This study found an association between zinc introduction and a reduction in economic burden of diarrhoea treatment to caregivers in underserved rural areas of Gujarat through more efficient patterns of care-seeking and content of care.
© The Author 2016. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Cost; India; developing countries; diarrhoea; implementation science; oral rehydration therapy; zinc

Mesh:

Substances:

Year:  2016        PMID: 27476499     DOI: 10.1093/heapol/czw083

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  5 in total

1.  An ethnographic exploration of diarrheal disease management in public hospitals in Bangladesh: From problems to solutions.

Authors:  Debashish Biswas; Raduan Hossin; Mahbubur Rahman; Kevin Louis Bardosh; Melissa H Watt; Mazharul Islam Zion; Hasnat Sujon; Md Mahbubur Rashid; M Salimuzzaman; Meerjady S Flora; Firdausi Qadri; Ashraful Islam Khan; Eric J Nelson
Journal:  Soc Sci Med       Date:  2020-07-10       Impact factor: 4.634

2.  Economic costs of hospitalized diarrheal disease in Bangladesh: a societal perspective.

Authors:  Abdur Razzaque Sarker; Marufa Sultana; Rashidul Alam Mahumud; Nausad Ali; Tanvir M Huda; M Salim Uzzaman; Sabbir Haider; Hafizur Rahman; Ziaul Islam; Jahangir A M Khan; Robert Van Der Meer; Alec Morton
Journal:  Glob Health Res Policy       Date:  2018-01-05

3.  Cost-effectiveness analysis of the diarrhea alleviation through zinc and oral rehydration therapy (DAZT) program in rural Gujarat India: an application of the net-benefit regression framework.

Authors:  Samuel D Shillcutt; Amnesty E LeFevre; Christa L Fischer-Walker; Sunita Taneja; Robert E Black; Sarmila Mazumder
Journal:  Cost Eff Resour Alloc       Date:  2017-06-08

4.  Prevalence and Health Care-Seeking Behavior for Childhood Diarrheal Disease in Bangladesh.

Authors:  Abdur Razzaque Sarker; Marufa Sultana; Rashidul Alam Mahumud; Nurnabi Sheikh; Robert Van Der Meer; Alec Morton
Journal:  Glob Pediatr Health       Date:  2016-11-30

5.  Quantifying and reducing statistical uncertainty in sample-based health program costing studies in low- and middle-income countries.

Authors:  Claudia L Rivera-Rodriguez; Stephen Resch; Sebastien Haneuse
Journal:  SAGE Open Med       Date:  2018-03-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.